| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |